Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Other (3)
• Plasma (single spun) (5)
• Saliva (1)
• Serum (4)
• Stool (2)
• Urine (random) (4)

Microscopic Assessment

• Affected (2)
• Not applicable (6)

Storage Temperature

• RT (2)
• -35°C to -18°C (1)
• -85°C to -60°C (6)

Associated Data

• Clinical records (5)
• Followup records (6)
• Freezer temperature logs (4)
• Genomic datasets (1)
• Imaging data (1)
• Microbiological results (3)
• Participant Ethnicity (4)
• Physiological/biochemical measurements (3)
• Pre-analytical data (1)
• Survey data (3)
• Treatment records (7)

Timeframe

• Immediate (4)
• 0 - 3 months (7)
• 3 - 6 months (4)
• > 6 months (3)

Participant Count

• 1 - 10 (1)
• 11 - 100 (1)
• 101 - 500 (5)
• 501 - 1000 (1)
• 1001 - 3000 (1)

Sex

• Male (1)
• Female (1)
• Both sexes (6)

Age Range

• Young adult (18 - 40 years) (7)

Biobank Services

• Ability to recontact (1)
• Cell culture (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (2)

Collection Type

• Clinical Trial (2)
• Cohort (1)
• Cross-sectional (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (5)
• No Export restriction (6)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (7)
• No Scope of use restriction (4)

Collection Status

• Completed (3)
• In progress (4)
• Not-started (1)

Access Condition

• Open to applicants (2)
• Open only through collaboration (4)
• Data access only (1)

Country

• Democratic Republic of the Congo (2)
• Peru (2)
• Philippines (1)
• Switzerland (1)
• Uganda (1)
• United States (1)

County